<DOC>
	<DOCNO>NCT02920762</DOCNO>
	<brief_summary>A study perform evaluate change prescribe behavior prescribers ER/LA opioids</brief_summary>
	<brief_title>Evaluation Changes Prescribing Behavior ER/LA Opioid Prescribers</brief_title>
	<detailed_description>A study perform evaluate change prescribe behavior prescribers . 1 . For product indicate use opioid-tolerant patient ( i.e. , fentanyl transdermal patch , extended-release hydromorphone pill extended-release morphine pill &gt; 90mg ) , describe trend proportion prescription product opioid-non-tolerant patient year precede availability REMS-compliant CE course compare proportion prescription opioid non-tolerant patient pre- versus post-REMS CE course availability 2 . For product whose label indicate high dosage strength use opioid-tolerant patient , describe trend proportion prescription prescribe opioid non-tolerant patient high start dosage strength ; compare proportion prescription product prescribe opioid non-tolerant patient high start dosage strength pre- versus post-REMS CE course availability 3 . Describe trend proportion prescription ER/LA opioids prescribe patient early refill prescription compare proportion pre- versus post-REMS CE course availability . 4 . Compare concomitant use benzodiazepine ER/LA opioids REMS implementation .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Subjects fill prescription product interest specified time period include .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>